Eleven Therapeutics has a total of 9 patents globally, out of which no patents have been granted. Of these 9 patents, more than 44% patents are active. Europe (EPO) is where Eleven Therapeutics has filed the maximum number of patents, followed by United States of America. Parallelly, United States of America seems to be the main focused R&D centre and also Israel is the origin country of Eleven Therapeutics.
Eleven Therapeutics was founded in the year 1993. Eleven Therapeutics is a biotech company that uses artificial intelligence to develop new treatments for diseases. They have created a special molecule, called SCSI-RNA that can be programmed to attack any disease or biological target. This could change the future of medicine.
Do read about some of the most popular patents of Eleven Therapeutics which have been covered by us in this article and also you can find Eleven Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Eleven Therapeutics patent portfolio.
How many patents does Eleven Therapeutics have?
Eleven Therapeutics has a total of 9 patents globally. These patents belong to 6 unique patent families. Out of 9 patents, 4 patents are active.
How Many Patents did Eleven Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Eleven Therapeutics Applications Filed | Eleven Therapeutics Patents Granted |
| 2024 | 1 | – |
| 2023 | 3 | – |
| 2022 | 2 | – |
| 2021 | 3 | – |
How many Eleven Therapeutics patents are Alive/Dead?
How Many Patents did Eleven Therapeutics File in Different Countries?
Countries in which Eleven Therapeutics Filed Patents
| Country | Patents |
| Europe (EPO) | 2 |
| United States of America | 1 |
Where are Research Centres of Eleven Therapeutics Patents Located?
List of Eleven Therapeutics Patents
| Eleven Therapeutics Patents | Title |
| EP4146808A4 | Utilizing Rna Interference Against Sars-Cov-2 |
| WO2024156788A1 | Artificial Polynucleotide Molecules For Enhanced Stability And Translation |
| WO2024047178A1 | A Method For Simultaneous Synthesis Of A Plurality Of Oligonucleotides |
| US20230203490A1 | Utilizing Rna Interference Against Sars-Cov-2 |
| EP4257684A1 | Reagents For Subcellular Delivery Of Cargo To Target Cells |
| WO2023194358A1 | Reagents For Subcellular Delivery Of Cargo To Target Cells |
| WO2023174845A1 | System And Method For High Throughput Evaluation Of Chemical Modifications Of Nucleic Acid Molecules |
| WO2022157762A1 | Genome Wide Screen Of Rnai Molecules |
| WO2021224918A1 | Utilizing Rna Interference Against Sars-Cov-2 |
What are Eleven Therapeutics key innovation segments?
What Technologies are Covered by Eleven Therapeutics?
The chart below distributes patents filed by Eleven Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Eleven Therapeutics thinks it’s important to protect particular technology inventions.
R&D Focus: How has Eleven Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Eleven Therapeutics?